Ifosfamide and Hyperkalemia - a phase IV clinical study of FDA data

Summary:

Hyperkalemia is reported as a side effect among people who take Ifosfamide (ifosfamide), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Methotrexate, and have Neoplasm malignant.

The phase IV clinical study analyzes which people have Hyperkalemia when taking Ifosfamide. It is created by eHealthMe based on reports of 21,274 people who have side effects when taking Ifosfamide from the FDA, and is updated regularly.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,957 drugs and 2,936 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

On May, 05, 2026

21,274 people reported to have side effects when taking Ifosfamide.
Among them, 23 people (0.11%) have Hyperkalemia.

Among these 23 people:

How long have people been on Ifosfamide when they have Hyperkalemia? *

What is the gender of people who have Hyperkalemia when taking Ifosfamide? *

female: 33.33 %
male: 66.67 %

What is the age of people who have Hyperkalemia when taking Ifosfamide? *

What are other drugs people take besides Ifosfamide? *

What are other side effects people have besides Hyperkalemia? *

Hypotension (abnormally low blood pressure): 9 people, 39.13%
Dyspnea (difficult or laboured breathing): 6 people, 26.09%
Acute Kidney Failure: 6 people, 26.09%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 6 people, 26.09%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 6 people, 26.09%
Nausea (feeling of having an urge to vomit): 6 people, 26.09%
Nausea And Vomiting: 6 people, 26.09%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 21.74%
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood): 5 people, 21.74%
Febrile Neutropenia (fever with reduced white blood cells): 5 people, 21.74%

What are the existing conditions these people have? *

Lymphoma (cancer that begins in immune system cells): 3 people, 13.04%
Neoplasm Malignant (cancer tumour): 3 people, 13.04%
T-Cell Type Acute Leukaemia (a form of cancer of the white blood cells): 2 people, 8.70%
Bone Sarcoma (bone cancer): 2 people, 8.70%
Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 2 people, 8.70%
Pain In Extremity: 2 people, 8.70%
Pain: 2 people, 8.70%
Thymoma (a tumour originating from the epithelial cells of the thymus): 2 people, 8.70%
White Blood Cell Count Decreased: 1 person, 4.35%
Metastases To Lung (cancer spreads to lung): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Ifosfamide and have Hyperkalemia?

- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ifosfamide:

Ifosfamide (21,285 reports)

Hyperkalemia treatments and more:

Hyperkalemia (78,084 reports)

Browse all side effects of Ifosfamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperkalemia:

Hyperkalemia (1,957 drugs)

Browse all the conditions that are associated with Hyperkalemia:

Hyperkalemia (2,936 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ifosfamide (the active ingredients of Ifosfamide) and Ifosfamide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.